|
ARL8B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.183000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.952000E-01 |
| Normal-vs-Stage2 |
3.646800E-01 |
| Normal-vs-Stage3 |
8.885400E-01 |
| Normal-vs-Stage4 |
5.264600E-01 |
| Stage1-vs-Stage2 |
1.430210E-01 |
| Stage1-vs-Stage3 |
7.067600E-01 |
| Stage1-vs-Stage4 |
8.174800E-01 |
| Stage2-vs-Stage3 |
2.868200E-01 |
| Stage2-vs-Stage4 |
1.738620E-01 |
| Stage3-vs-Stage4 |
6.274600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.854200E-01 |
| Normal-vs-AfricanAmerican |
3.086000E-01 |
| Normal-vs-Asian |
5.744400E-01 |
| Caucasian-vs-AfricanAmerican |
4.390600E-01 |
| Caucasian-vs-Asian |
7.743600E-01 |
| AfricanAmerican-vs-Asian |
6.136000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.661800E-01 |
| Normal-vs-Female |
4.704600E-01 |
| Male-vs-Female |
1.237240E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.984400E-01 |
| Normal-vs-Age(41-60Yrs) |
8.625400E-01 |
| Normal-vs-Age(61-80Yrs) |
4.605800E-01 |
| Normal-vs-Age(81-100Yrs) |
7.916400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.865400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.816300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.533800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.970400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.737200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.161200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.532180E-01 |
| Classical-VS-Follicular |
2.40819999999253E-05 |
| Classical-VS-Other |
5.684500E-02 |
| Classical-VS-Normal |
1.958420E-01 |
| Tall-VS-Follicular |
3.044700E-04 |
| Tall-VS-Other |
1.560190E-02 |
| Tall-VS-Normal |
2.224200E-02 |
| Follicular-VS-Other |
8.090200E-01 |
| Follicular-VS-Normal |
1.975510E-02 |
| Other-VS-Normal |
1.268600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.712200E-01 |
| Normal-vs-N1 |
8.731600E-01 |
| N0-vs-N1 |
3.835000E-01 |
|
|
